Epilepsy is a neurological disease. It is a chronic disorder of the central nervous system defined by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. Every major medical authority, including the World Health Organization and the International League Against Epilepsy (ILAE), classifies it this way. Roughly 51.7 million people worldwide were living with epilepsy as of 2021.
What Makes Epilepsy Neurological
A seizure happens when a population of neurons in the brain fires excessively and in unison. Normally, brain cells communicate through carefully timed electrical signals. During a seizure, a large group of neurons depolarizes at once, producing a burst of rapid-fire electrical activity that overwhelms normal brain function. This synchronized burst shows up as a characteristic spike on an EEG recording.
At the cellular level, the process starts when calcium floods into neurons from outside the cell. That triggers sodium channels to open, generating a cascade of repeated electrical impulses far faster than normal. This sequence, known as a paroxysmal depolarizing shift, is the fundamental building block of a seizure. Because the root cause is disordered electrical signaling in brain tissue, epilepsy sits firmly in the category of neurological diseases, alongside conditions like multiple sclerosis, Parkinson’s disease, and stroke.
How Epilepsy Is Formally Defined
The ILAE’s clinical definition requires at least one of three criteria: two unprovoked seizures occurring more than 24 hours apart, a single unprovoked seizure with at least a 60% chance of another seizure within the next 10 years, or a recognized epilepsy syndrome. This definition matters because a single seizure alone does not equal epilepsy. The pattern of recurrence, or a high enough probability of recurrence, is what separates epilepsy from an isolated event.
Epilepsy is also considered resolved if a person has been seizure-free for 10 years and off medication for at least the last 5, or if they had an age-dependent syndrome and have aged out of it.
Types and Causes
The ILAE classifies epilepsy on three levels. First, the seizure type: focal (starting in one hemisphere of the brain), generalized (appearing simultaneously in both hemispheres), or unknown origin. Second, the epilepsy type, which groups patients by whether they have focal epilepsy, generalized epilepsy, or a combination of both. Third, the epilepsy syndrome, a more specific diagnosis that considers seizure patterns, EEG findings, and other clinical features together.
At every stage, doctors are expected to consider what’s causing the epilepsy. The ILAE recognizes six broad categories of cause:
- Structural: a visible abnormality in the brain, such as damage from a stroke, tumor, or traumatic injury
- Genetic: a known or presumed gene variant directly responsible for seizures
- Infectious: seizures resulting from infections like meningitis, encephalitis, or neurocysticercosis
- Metabolic: disorders of metabolism that produce seizures as a core symptom
- Immune: autoimmune conditions that attack the brain and trigger seizures
- Unknown: no identifiable cause despite investigation
Many people with epilepsy fall into the unknown category. Having no identifiable cause doesn’t change the neurological nature of the condition. The seizures still originate from abnormal brain activity.
How Epilepsy Differs From Psychiatric Seizures
Not every event that looks like a seizure is epilepsy. Psychogenic nonepileptic events (sometimes called nonepileptic seizures) can closely resemble epileptic seizures but are driven by psychological or psychiatric factors rather than abnormal electrical discharges in the brain. About 12% of people with epilepsy also experience these nonepileptic events, which can complicate diagnosis.
The distinction is important. During an epileptic seizure, the intense muscle activity and disrupted brain signaling cause measurable metabolic changes, including a shift toward acidosis as muscles work anaerobically. Nonepileptic events generally don’t produce these metabolic shifts because the physical movements tend to be less intense. An EEG during an epileptic seizure shows the characteristic abnormal electrical patterns; during a nonepileptic event, brain activity looks normal. This is the clearest confirmation that epilepsy is neurological in origin, while nonepileptic seizures have a different, psychiatric basis.
Mental Health Effects of a Neurological Disease
Although epilepsy is neurological, it has deep ties to mental health. People with epilepsy are two to five times more likely to develop a psychiatric disorder than the general population, and about one in three will receive a psychiatric diagnosis in their lifetime.
Depression is the most common overlap. Roughly 23% of adults with epilepsy experience active depression, a rate 2.7 times higher than in people without epilepsy. Anxiety disorders affect about 20%, with generalized anxiety being the most frequent type. Psychosis, while less common, occurs in about 5.6% of people with epilepsy, a rate nearly eight times higher than in the general population.
Children with epilepsy face their own set of challenges. A large Norwegian study of over one million children found that 43% of those with epilepsy had developmental or psychiatric conditions. The risk of autism was roughly 11 times higher than in the general child population, and ADHD risk was about 5 times higher. These numbers reflect the broad impact that disrupted brain circuitry can have beyond seizures themselves.
Treatment and Seizure Control
The primary treatment for epilepsy is anti-seizure medication. For most people, the first medication tried is the most important one. In studies of newly diagnosed patients, about 67% achieved seizure freedom with their first medication. When researchers looked only at patients whose medication was changed specifically because it wasn’t working (rather than for side effects), that number rose to about 75%.
For the roughly one-third of people whose seizures aren’t fully controlled by the first medication, additional options include trying a different drug, combining medications, or pursuing surgical evaluation. Some forms of epilepsy, particularly those with a clear structural cause in a specific brain region, respond well to surgery. Others may benefit from devices that modulate brain activity or from dietary approaches like the ketogenic diet. The range of available treatments continues to expand, but the fundamental goal remains the same: stopping the abnormal electrical activity that defines this neurological disease.

